# First Hawaiian, Inc.: financial statements, quarterly

FHB · Nasdaq · CIK 36377 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fhb.md) · [Financials](/companies/fhb/financials.md) · [Filings](/companies/fhb/filings.md) · [Insiders](/companies/fhb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fhb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [203](/filings/0001558370-24-014253.md) | [210 d](/filings/0001104659-26-021544.md) | [206](/filings/0001558370-25-006291.md) | [205](/filings/0001558370-25-010092.md) | [210](/filings/0001104659-25-105580.md) | [188 d](/filings/0001104659-26-021544.md) | [211](/filings/0001104659-26-054867.md) | [218](/filings/0001104659-26-089785.md) | [226](/filings/0001104659-25-105580.md) | [226 d](/filings/0001104659-26-021544.md) | [220](/filings/0001104659-26-054867.md) | [231](/filings/0001104659-26-089785.md) |
| Interest expense | $m | [82.7](/filings/0001558370-23-017755.md) | [89.2 d](/filings/0001558370-24-001995.md) | [90.5](/filings/0001558370-24-006809.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [18.1](/filings/0001558370-24-014253.md) | [15.0 d](/filings/0001104659-26-021544.md) | [16.5](/filings/0001558370-25-006291.md) | [18.8](/filings/0001558370-25-010092.md) | [15.0](/filings/0001104659-25-105580.md) | [12.2 d](/filings/0001104659-26-021544.md) | [17.7](/filings/0001104659-26-054867.md) | [14.9](/filings/0001104659-26-089785.md) | [22.3](/filings/0001104659-25-105580.md) | [23.1 d](/filings/0001104659-26-021544.md) | [19.7](/filings/0001104659-26-054867.md) | [21.9](/filings/0001104659-26-089785.md) |
| Net income | $m | [58.2](/filings/0001558370-24-014253.md) | [47.5 d](/filings/0001104659-26-021544.md) | [54.2](/filings/0001558370-25-006291.md) | [61.9](/filings/0001558370-25-010092.md) | [61.5](/filings/0001104659-25-105580.md) | [52.5 d](/filings/0001104659-26-021544.md) | [59.2](/filings/0001104659-26-054867.md) | [73.2](/filings/0001104659-26-089785.md) | [73.8](/filings/0001104659-25-105580.md) | [69.9 d](/filings/0001104659-26-021544.md) | [67.8](/filings/0001104659-26-054867.md) | [73.4](/filings/0001104659-26-089785.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001558370-24-014253.md) | not reported | [0.42](/filings/0001558370-25-006291.md) | [0.48](/filings/0001558370-25-010092.md) | [0.48](/filings/0001104659-25-105580.md) | not reported | [0.47](/filings/0001104659-26-054867.md) | [0.58](/filings/0001104659-26-089785.md) | [0.59](/filings/0001104659-25-105580.md) | not reported | [0.55](/filings/0001104659-26-054867.md) | [0.60](/filings/0001104659-26-089785.md) |
| Basic EPS | $ per share | [0.46](/filings/0001558370-24-014253.md) | not reported | [0.42](/filings/0001558370-25-006291.md) | [0.48](/filings/0001558370-25-010092.md) | [0.48](/filings/0001104659-25-105580.md) | not reported | [0.47](/filings/0001104659-26-054867.md) | [0.58](/filings/0001104659-26-089785.md) | [0.59](/filings/0001104659-25-105580.md) | not reported | [0.55](/filings/0001104659-26-054867.md) | [0.60](/filings/0001104659-26-089785.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [24.9](/filings/0001558370-23-017755.md) | [24.9](/filings/0001104659-26-021544.md) | [24.3](/filings/0001558370-24-006809.md) | [24.0](/filings/0001558370-24-010868.md) | [23.8](/filings/0001558370-24-014253.md) | [23.8](/filings/0001104659-26-021544.md) | [23.7](/filings/0001558370-25-006291.md) | [23.8](/filings/0001558370-25-010092.md) | [24.1](/filings/0001104659-25-105580.md) | [24.0](/filings/0001104659-26-089785.md) | [24.3](/filings/0001104659-26-054867.md) | [23.6](/filings/0001104659-26-089785.md) |
| Total liabilities | $bn | [22.6](/filings/0001558370-23-017755.md) | [22.4](/filings/0001558370-25-001943.md) | [21.8](/filings/0001558370-24-006809.md) | [21.4](/filings/0001558370-24-010868.md) | [21.1](/filings/0001558370-24-014253.md) | [21.2](/filings/0001104659-26-021544.md) | [21.1](/filings/0001558370-25-006291.md) | [21.1](/filings/0001558370-25-010092.md) | [21.4](/filings/0001104659-25-105580.md) | [21.2](/filings/0001104659-26-089785.md) | [21.5](/filings/0001104659-26-054867.md) | [20.8](/filings/0001104659-26-089785.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.5](/filings/0001558370-23-017755.md) | [0.5](/filings/0001558370-25-001943.md) | [0.5](/filings/0001558370-24-006809.md) | [0.5](/filings/0001558370-24-010868.md) | [0.3](/filings/0001558370-24-014253.md) | [0.3](/filings/0001104659-26-021544.md) | [0.3](/filings/0001558370-25-006291.md) | [0.3](/filings/0001558370-25-010092.md) | [0.0](/filings/0001104659-25-105580.md) | [0.0](/filings/0001104659-26-021544.md) | not reported | not reported |
| Shareholders' equity | $bn | [2.4](/filings/0001558370-24-014253.md) | [2.5](/filings/0001104659-26-021544.md) | [2.5](/filings/0001558370-25-010092.md) | [2.6](/filings/0001104659-25-105580.md) | [2.6](/filings/0001104659-25-105580.md) | [2.6](/filings/0001104659-26-089785.md) | [2.6](/filings/0001104659-26-089785.md) | [2.7](/filings/0001104659-26-089785.md) | [2.7](/filings/0001104659-25-105580.md) | [2.8](/filings/0001104659-26-089785.md) | [2.8](/filings/0001104659-26-089785.md) | [2.8](/filings/0001104659-26-089785.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [26.2 d](/filings/0001558370-24-014253.md) | [41.2 d](/filings/0001104659-26-021544.md) | [66.6](/filings/0001558370-25-006291.md) | [78.2 d](/filings/0001558370-25-010092.md) | [58.9 d](/filings/0001104659-25-105580.md) | [114 d](/filings/0001104659-26-021544.md) | [36.7](/filings/0001104659-26-054867.md) | [136 d](/filings/0001104659-26-089785.md) | [57.1 d](/filings/0001104659-25-105580.md) | [105 d](/filings/0001104659-26-021544.md) | [160](/filings/0001104659-26-054867.md) | [13.2 d](/filings/0001104659-26-089785.md) |
| Capital expenditure | $m | [4.1 d](/filings/0001558370-24-014253.md) | [7.7 d](/filings/0001104659-26-021544.md) | [4.9](/filings/0001558370-25-006291.md) | [6.0 d](/filings/0001558370-25-010092.md) | [6.6 d](/filings/0001104659-25-105580.md) | [11.4 d](/filings/0001104659-26-021544.md) | [8.1](/filings/0001104659-26-054867.md) | [11.2 d](/filings/0001104659-26-089785.md) | [7.6 d](/filings/0001104659-25-105580.md) | [4.9 d](/filings/0001104659-26-021544.md) | [4.3](/filings/0001104659-26-054867.md) | [5.5 d](/filings/0001104659-26-089785.md) |
| Dividends paid | $m | [33.2 d](/filings/0001558370-24-014253.md) | [33.2 d](/filings/0001104659-26-021544.md) | [33.2](/filings/0001558370-25-006291.md) | [33.2 d](/filings/0001558370-25-010092.md) | [33.2 d](/filings/0001104659-25-105580.md) | [33.1 d](/filings/0001104659-26-021544.md) | [32.9](/filings/0001104659-26-054867.md) | [33.6 d](/filings/0001104659-26-089785.md) | [32.3 d](/filings/0001104659-25-105580.md) | [32.2 d](/filings/0001104659-26-021544.md) | [33.1](/filings/0001104659-26-054867.md) | [31.7 d](/filings/0001104659-26-089785.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [25.0](/filings/0001104659-26-054867.md) | [25.0 d](/filings/0001104659-26-089785.md) | [24.0 d](/filings/0001104659-25-105580.md) | [26.0 d](/filings/0001104659-26-021544.md) | [32.0](/filings/0001104659-26-054867.md) | [0.0 d](/filings/0001104659-26-089785.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [128](/filings/0001558370-23-017755.md) | [128](/filings/0001558370-24-006809.md) | [128](/filings/0001558370-24-010868.md) | [128](/filings/0001558370-24-014253.md) | [128](/filings/0001558370-25-006291.md) | [128](/filings/0001558370-25-010092.md) | [129](/filings/0001104659-25-105580.md) | [127](/filings/0001104659-26-054867.md) | [126](/filings/0001104659-26-089785.md) | [125](/filings/0001104659-25-105580.md) | [123](/filings/0001104659-26-054867.md) | [122](/filings/0001104659-26-089785.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 121,680,634 at 2026-07-24, from the cover of the [10-Q filed 2026-08-03](/filings/0001104659-26-089785.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.